Strategies for Treating Alzheimer’s: Current Approaches and Future Perspectives

Strategies for Treating Alzheimer’s: Current Approaches and Future Perspectives

Introduction and Purpose: Alzheimer’s disease is the most common cause of dementia, affecting millions of people worldwide and posing a significant challenge to modern medicine. This review explores the available treatment options, their limitations, and the future directions of research that ma...

Full description

Saved in:

Bibliographic Details
Main Authors:	Adriana Skuba, Katarzyna Załuska, Agnieszka Świdniak, Marta Biskup, Aleksandra Bartoszek, Karolina Kopeć, Agnieszka Marut, Jagoda Misiuk, Julia Adamiuk, Sylwia Nykiel
Format:	Article
Language:	English
Published:	Nicolaus Copernicus University in Toruń 2025-05-01
Series:	Quality in Sport
Subjects:	Alzheimer's disease amyloid tau inflammation dementia acetylcho
Online Access:	https://apcz.umk.pl/QS/article/view/58829
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Physical Exercise as a Therapeutic Strategy in Alzheimer’s Disease: Mechanisms and Benefits
by: Aleksandra Bartoszek, et al.
Published: (2025-05-01)

The Impact of Omega-3 Fatty Acids on the Onset and Management of Alzheimer's Disease
by: Marta Biskup, et al.
Published: (2025-05-01)

The Role of Omega-3 Fatty Acids in Cognitive Health: From Development to Aging and Neurodegenerative Protection
by: Julia Adamiuk, et al.
Published: (2025-05-01)

Testosterone therapy for hypoactive sexual desire disorder in women
by: Jagoda Misiuk Misiuk, et al.
Published: (2025-05-01)

The Dietary Fats: A Comprehensive Study about the Influence of Different Types of Fats on General Health and Developing Diseases
by: Sylwia Nykiel, et al.
Published: (2025-04-01)

The Medical Power of Capsaicin: Mechanisms, Applications, and Innovations
by: Katarzyna Załuska, et al.
Published: (2025-04-01)

HPV Vaccine: Current Data, Efficacy, and Clinical Implications
by: agnieszka marut, et al.
Published: (2025-05-01)

Penetration of heavy metals into breast milk and their impact on infant health - research analysis and literature review
by: Agnieszka Świdniak, et al.
Published: (2025-06-01)

Using cerebrospinal fluid biomarkers to diagnose Alzheimer’s disease: an Australian perspective
by: Dhamidhu Eratne, et al.
Published: (2024-12-01)

From clinical phenotype to proteinopathy: molecular neuroimaging in neurodegenerative dementias
by: Adalberto Studart-Neto, et al.
Published: (2022-08-01)

Recent advances in immunotherapy targeting amyloid-beta and tauopathies in Alzheimer’s disease
by: Sha Sha, et al.
Published: (2026-02-01)

Interplay Between Aging and Tau Pathology in Alzheimer’s Disease: Mechanisms and Translational Perspectives
by: Mohammed Alrouji, et al.
Published: (2025-06-01)

Physiopathological mechanisms underlying Alzheimer’s disease: a narrative review
by: Eliasz Engelhardt, et al.
Published: (2024-12-01)

miR‐132 loss de‐represses ITPKB and aggravates amyloid and TAU pathology in Alzheimer's brain
by: Evgenia Salta, et al.
Published: (2016-08-01)

Soluble P‐tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau
by: Niklas Mattsson‐Carlgren, et al.
Published: (2021-05-01)

Screening of Aβ and phosphorylated tau status in the cerebrospinal fluid through machine learning analysis of portable electroencephalography data
by: Masahiro Hata, et al.
Published: (2025-01-01)

Tau‐targeting nanoparticles for treatment of Alzheimer's disease
by: Shreya Pawar, et al.
Published: (2025-04-01)

Deletion of Murine APP Aggravates Tau and Amyloid Pathologies in the 5xFADXTg30 Alzheimer’s Disease Model
by: Kunie Ando, et al.
Published: (2025-01-01)

Blood essential trace elements and Alzheimer’s disease biomarkers in midlife
by: Xin Wang, et al.
Published: (2025-05-01)

Behavioral and psychological symptoms of dementia and Alzheimer’s disease progression in Down syndrome
by: Melissa R. Jenkins, et al.
Published: (2025-04-01)

Alzheimer’s Disease in the Age of Precision Medicine: Advances in Pathophysiology, Clinical Management and Therapeutic Strategies
by: Michał Piotrowski, et al.
Published: (2025-04-01)

Associations of Plasma and CSF Osteocalcin Levels With CSF ATN Biomarkers and Cognitive Functions in Alzheimer's Disease
by: Xian‐Le Bu, et al.
Published: (2025-07-01)

Integrative network analysis reveals novel moderators of Aβ-Tau interaction in Alzheimer's disease
by: Akihiro Kitani, et al.
Published: (2025-04-01)

Novel targets for the treatment and prevention of Alzheimer's disease in the European population, inspiration from amyloid beta and tau protein
by: Xifeng Wang, et al.
Published: (2024-10-01)

Alzheimer’s Disease in the Context of an Aging Society: Challenges and Future Directions
by: Aleksandra Boral, et al.
Published: (2025-07-01)

The Potential Mechanism and the Role of Antioxidants in Mitigating Oxidative Stress in Alzheimer’s Disease
by: Rayees Ahmad Naik, et al.
Published: (2025-02-01)

Autophagy and Alzheimer’s Disease: Mechanisms and Impact Beyond the Brain
by: Zaw Myo Hein, et al.
Published: (2025-06-01)

Cerebrospinal Fluid Classical Biomarker Levels in Mixed vs. Pure A<sup>+</sup>T<sup>+</sup> (A<sup>+</sup>T<sub>1</sub><sup>+</sup>) Alzheimer’s Disease
by: Ioanna Tsantzali, et al.
Published: (2024-12-01)

Analysis of cognitive status of Alzheimer’s disease’s subjects and its association with biomarkers (amyloid beta and tau proteins) using NACC data
by: Vaghawan Prasad Ojha, et al.
Published: (2025-04-01)

The origin of Alzheimer’s disease: Prions?
by: Dongchuan Yang, et al.
Published: (2025-05-01)

Rock inhibitors in Alzheimer’s disease
by: Chao Zheng, et al.
Published: (2025-03-01)

Passive Anti-amyloid Beta Monoclonal Antibodies: Lessons Learned over Past 20 Years
by: Alexandra Wicker, et al.
Published: (2024-10-01)

Rest‐activity rhythm characteristics associated with lower cognitive performance and Alzheimer's disease biomarkers in midlife women
by: Alexandra Paget‐Blanc, et al.
Published: (2025-04-01)

Free water derived by multi‐shell diffusion MRI reflects tau/neuroinflammatory pathology in Alzheimer's disease
by: Moto Nakaya, et al.
Published: (2022-01-01)

Clinical and neuropathological associations of plasma Aβ42/Aβ40, p‐tau217 and neurofilament light in sporadic frontotemporal dementia spectrum disorders
by: Binita Rajbanshi, et al.
Published: (2025-01-01)

New Possibilities for Evaluating Markers of Alzheimer's Disease in Blood Serum
by: S. V. Vorobev, et al.
Published: (2025-06-01)

In search of Alzheimer’s disease treatment methods: trends of clinical trials
by: G. Pakulaitė, et al.
Published: (2018-03-01)

Modeling Alzheimer’s Disease: A Review of Gene-Modified and Induced Animal Models, Complex Cell Culture Models, and Computational Modeling
by: Anna M. Timofeeva, et al.
Published: (2025-05-01)

Cerebrospinal fluid amyloid beta and tau protein: Biomarkers for Alzheimer's disease
by: Mandić Gorana, et al.
Published: (2008-01-01)

Developing non-invasive molecular markers for early risk assessment of Alzheimer's disease
by: Tapas K. Sur, et al.
Published: (2025-06-01)